Cita APA

Sarli, M., Novoa, M. B., Mazzucco, M. N., Signorini Porchietto, M. L., Echaide, I. E., Torioni de Echaide, S. M., & Primo, M. E. (2020). A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge. Web

Citación estilo Chicago

Sarli, Macarena, María Belén Novoa, Matilde N. Mazzucco, Marcelo Lisandro Signorini Porchietto, Ignacio Eduardo Echaide, Susana Marta Torioni de Echaide, and Maria Evangelina Primo. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective against a Virulent Challenge. 2020.

Cita MLA

Sarli, Macarena, et al. A Vaccine Using Anaplasma Marginale Subdominant Type IV Secretion System Recombinant Proteins Was Not Protective against a Virulent Challenge. 2020.